Whether you're a patient or medical professional, you need to read this and take action. If your doctor doesn’t have access to purchase the medication at the low international price, Medicare/Medicaid will not reimburse the physician. The "Most Favored Nation" (MFN) is mandatory for all providers participating in the Medicare program. There are limited exemptions for payable Medicare Part B drugs based on reasonable costs. Medicare and Medicaid furnished a plan to adjust financial reimbursements to health care providers making it near impossible for them to stay open. MFN rule recently released by the administration, allows foreign countries to determine the cost of Part B medications. Since U.S. doctors are not allowed to purchase medicines internationally, unless drug companies lower prices in the U.S., small physician practices will fail or stop offering certain treatments such as rheumatological infusions.

Watch Interview with Dr. Eudy.


HOW CAN I HELP? Comment on this rule directly to the government! Voice your opposition. Visit: federalregister.gov. Communicate directly with your legislators. The Coalition of State Rheumatology Organizations (CSRO) encourages you to voice your concerns urging to delay the rule so they have time to dialogue the new policy with CMS (Centers for Medicare & Medicaid Services). CSRO has an Advocacy tab with an Action Center selection on their website to make it easy to respond to U.S. Senators and Representatives. Go to: csro.info.
Action Links:
federalregister.gov | csro.info

Click here for more information.

Author: Jennie Welter

Share